As expected, ICG Enterprise Trust plc (LON:ICGT) results to end-January 2026 showed the benefit of its defensive growth strategy focusing on high-quality companies, which i) attracts through-cycle interest from buyers, ii) saw good operating company EBITDA and revenue growth, and iii) meant software exposure is modest in size and focused in areas that may benefit from AI adoption. Multiple market dynamics are structurally favourable to further exits, and while there may be quarterly noise around global uncertainties, medium-term realisations look good. The discount appears anomalous with its performance, a conservative NAV and the outlook.
- Long-term performance: ICG Enterprise Trust operating companies have delivered superior long-term revenue and EBITDA growth, margin expansion and strong exit volumes and uplifts through varying market conditions. Short-term noise has driven another year of below-average portfolio growth and NAV total returns.
- Capital allocations: ICGT continues to invest to generate long-term returns and re-build the portfolio after an exceptional year of realisations. In addition, it has continued its progressive dividend policy (10-year 10% CAGR) and both of its long-term, discount-agnostic and opportunistic buyback programmes.
- Valuation: ICGT’s NAV valuations are conservative (regular realisation uplifts), the ratings undemanding, and the ongoing carry value against cost is modest. The 32% discount to NAV is anomalous, we believe, with defensive, market-beating returns, and is above pre-COVID-19 levels. The 2026E yield is 2.8%.
- Risks: PE’s post-expense, long-term returns are market-beating, but it is an above-average cost model. Sentiment may be adverse to the perceived interest rate risk, IPO market, and performance in economic slowdowns. We believe ICGT’s permanent capital structure is right for illiquid assets.
- Investment summary: ICG Enterprise Trust has consistently generated superior returns, by identifying managers and investments where value can be added, with a strategic focus on defensive growth and exploiting ICG synergies. Valuations appear conservative, and governance is strong. It seems anomalous, in our view, to have this record of outperformance and to trade at a discount to NAV.
